Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.  Learn more >>
Article |

Stop faulty garlic claims

The Center for Science in the Public Interest submitted formal petitions to both Food and Drug Administration and the Federal Trade Commission in December to halt labeling and advertising claims that garlic supplements reduce cholesterol by some manufacturers of dietary supplements.
Print Reprint
FILED IN:  Machinery  > Labeling
     

CSPI cited Kwai Dietary Supplement Kwai Heart Fit Garlic One A Day Cholesterol Health Dietary Supplement and Nature Made Herbs Garlic Supplement as specific examples of products whose label claims should be banned. CSPI noted that the Agency for Healthcare Research and Quality of the U.S. Department of Health and Human Services found that garlic supplements caused a slight reduction in cholesterol levels when taken for one to three months but not when taken for six months or longer. In the long run the supplements did not improve health and therefore any label or advertising claims should not be permitted according to CSPI.

Comments(0)

Add new comment

Related Sponsored Content

E-BOOK SPECIAL REPORT
42 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!
x

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
Each newsletter ranges in frequency from once per month to a few times per month at most.